Welcome to AIRBEST project
Advanced Inflammation Recognition through Breath Sensing Technology
Chronic obstructive pulmonary disease (COPD) is a lung disease that affects the airways. The most common causes of COPD are smoking and pollution. COPD is the most common and fourth leading cause of death worldwide. According to a WHO report, approximately 3.5 million deaths occurred in 2021.
AIRBEST is an EUREKA-Eurostars project focused on advancing technologies in respiratory diagnostics. The project aims to enable individuals to monitor their health. It holds potential for improving the early detection and management of respiratory conditions, ultimately enhancing overall health.
The AIRBEST initiative unites an esteemed international consortium of technology specialists and innovative SMEs to enhance diagnostics for COPD patients.
Project aim
The AIRBEST project aims to develop a next-generation exhaled breath-measuring instrument that accurately detects and informs users and healthcare providers about COPD.
Project overview
- Budget: 1.5M Euro
- Duration: 3 Years
- Partners: 3
- Countries: France and Sweden
Project objective
To develop an advance diagnostic instrument for the detection of lung disease.